Wiener medizinische Wochenschrift (1946) · 2005
[Pharmacological management of stable COPD].
Сравнительное исследованиеАннотация на английскомСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rauscher Helmuth
Аннотация
Pharmacotherapy for stable COPD depends on the severity of the disease. Thus, decisions on therapeutic interventions should be based not solely on the degree of airflow obstruction but also on symptoms, exercise tolerance, frequency and severity of exacerbations, and health-related quality of life. The progressive nature of COPD necessitates a stepwise increase of medication (step-up approach) depending on the severity of the disease. Although none of the currently available medications has been shown to modify the abnormal reaction to inhaled noxious particles and gases that lead to COPD, pharmacotherapy has beneficial effects on the clinical course of the disease by controlling symptoms, increasing exercise tolerance and improving general health status.
Предметные рубрики MeSH
Administration, InhalationAdministration, OralAdrenergic beta-AntagonistsAnti-Bacterial AgentsBronchodilator AgentsCholinergic AntagonistsControlled Clinical Trials as TopicDrug Therapy, CombinationExpectorantsForced Expiratory VolumeGlucocorticoidsHealth StatusHumansImmunologic FactorsPractice Guidelines as TopicProspective StudiesPulmonary Disease, Chronic ObstructiveQuality of LifeTime FactorsXanthines